<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Familial hyperlipidemia type 2" Version="20210520" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Familial hyperlipidemias are classified according to the Fredrickson classification. Type II familial hyperlipidemia is divided into 2 subtypes, IIa and IIb. 
IIa is linked with mutations in the LDL receptor (LDLR) or genes that regulate the LDL uptake. Therefore, we see an increase of LDL with type IIa familial hyperlipidemia. IIa can be subdived into 4 different types. FHCL1 is caused by direct mutations of the LDLR. This FCHL1 has different phenotypes linked to it which are cause by mutations in APOA2, EPHX2 and GHR. FCHL2 is caused by mutations in APOB, which acts as a ligand for the LDLR. FHCL3 is caused by mutations in PCSK9 which binds to LDLR to inhibit LDL uptake. Lastly, FHCL4 is linked with mutations in LDLRAP1, which stimulates receptor binding.
Typ IIB familial hyperlipidemia is known as familial combined hyperlipidemia. This type has shown an increase of both LDL and VLDL. Type IIB can be divided into 3 subtypes. FCHL1 is caused by mutations in USF1 which plays a role in cellular transcription. However, it is unclear how exactly this is linked to the lipid metabolism. HYPLIP2 is caused by mutations in APOB, which is linked to the reduced LDL. APOB is also a primmary apolipoprotein for VLDL. Lastly, FCHL3 is linked to LPL mutations, which is mostly linnked to hydrolizing the VLDL into IDL.</Comment>
  <Graphics BoardWidth="1725.347557280978" BoardHeight="887.5"/>
  <DataNode TextLabel="FHCL1" GraphId="a1771">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="FHCL4" GraphId="c5332">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="FCHL2" GraphId="c761d">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="FCHL1" GraphId="cb3ed">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="FHCL3" GraphId="cfc7b">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="HYPLIP2" GraphId="f1bf9">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="FCHL3" GraphId="f8352">
    <Comment>Unclear what this subtypes is seperated on compared to the main class of combined hyperlipidemia. Wikidata is shared for both.</Comment>
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="USF1" GraphId="fe276" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="DHET" GraphId="ff61b" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Familial combined hyperlipidemia" GraphId="adca4">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="EET" GraphId="c88e2" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Familial hypercholesterolemia" GraphId="db44f">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="Familial hyperlipidemia" GraphId="f3896">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="EPHX2" GraphId="f70e9" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="GHR" GraphId="d90d0" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="PCSK9" GraphId="d36f9" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="LDLRAP1" GraphId="e15f7" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="APOB" GraphId="ef1cd" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="VLDL" GraphId="e22d1" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="APOA2" GraphId="df1c4" Type="GeneProduct" GroupRef="bc8e0">
        </DataNode>
  <DataNode TextLabel="Cholesterol" GraphId="d6f96" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="HDL" GraphId="f3ec7" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="LDL" GraphId="d15da" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="APOA4" GraphId="e7639" Type="GeneProduct" GroupRef="bc8e0">
        </DataNode>
  <DataNode TextLabel="Lipoprotein" GraphId="b3be1" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="IDL" GraphId="bde49" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="LIPC" GraphId="c7dfe" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="APOA1" GraphId="f5643" Type="GeneProduct" GroupRef="bc8e0">
        </DataNode>
  <DataNode TextLabel="LCAT" GraphId="c5dcd" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="LDLR" GraphId="eb6d4" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="PLTP" GraphId="be97f" Type="GeneProduct" GroupRef="bc8e0">
        </DataNode>
  <DataNode TextLabel="LPL" GraphId="b64a3" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="GPIHBP1" GraphId="cb34c" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="GPIHBP1" GraphId="a65d4" Type="GeneProduct" GroupRef="b6ea1">
        </DataNode>
  <DataNode TextLabel="LPL" GraphId="c0414" Type="GeneProduct" GroupRef="b6ea1">
        </DataNode>
  <DataNode TextLabel="CETP" GraphId="d4e9a" Type="GeneProduct">
    <BiopaxRef>d5e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="CETP" GraphId="f0279" Type="GeneProduct">
    <BiopaxRef>d5e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="CETP" GraphId="da02f" Type="GeneProduct">
    <BiopaxRef>d5e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Cholesterol" GraphId="ba284" Type="Metabolite" GroupRef="eb1af">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Triglyceride" GraphId="f6c5e" Type="Metabolite" GroupRef="eb1af">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Phospholipid" GraphId="acc60" Type="Metabolite" GroupRef="eb1af">
    <Graphics Color="0000ff"/>
    </DataNode>
  <Interaction GraphId="id7d752779">
    <BiopaxRef>b49</BiopaxRef>
    <Graphics>
      <Point GraphRef="d90d0"/>
      <Point GraphRef="f3ec7" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idddfd35b4">
    <BiopaxRef>f0a</BiopaxRef>
    <Graphics>
      <Point GraphRef="ef1cd"/>
      <Point GraphRef="d15da" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf9de3300">
    <BiopaxRef>dae</BiopaxRef>
    <Graphics>
      <Point GraphRef="c88e2"/>
      <Point GraphRef="ff61b" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="c9373"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f3f7e">
    <BiopaxRef>e53</BiopaxRef>
    <Graphics>
      <Point GraphRef="e15f7"/>
      <Point GraphRef="eb6d4" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e5190">
    <BiopaxRef>b55</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d36f9"/>
      <Point GraphRef="eb6d4" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa831">
    <BiopaxRef>e47</BiopaxRef>
    <Graphics>
      <Point GraphRef="f70e9"/>
      <Point GraphRef="c9373" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd1b3">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="b3fe7"/>
      <Point GraphRef="e1bbc" ArrowHead="mim-catalysis"/>
      <Anchor Position="0.22273617500313048" Shape="None" GraphId="fdde5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dfb19">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="cb34c"/>
      <Point GraphRef="b3fe7" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2c6e">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="b64a3"/>
      <Point GraphRef="cb34c" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dfa30">
    <BiopaxRef>edb</BiopaxRef>
    <Graphics>
      <Point GraphRef="d4e9a"/>
      <Point GraphRef="a6ac8" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9e9b">
    <BiopaxRef>bab</BiopaxRef>
    <Graphics>
      <Point GraphRef="c5dcd"/>
      <Point GraphRef="b1b7b" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fb880">
    <BiopaxRef>f2e</BiopaxRef>
    <BiopaxRef>edb</BiopaxRef>
    <BiopaxRef>d5e</BiopaxRef>
    <Graphics>
      <Point GraphRef="d4e9a"/>
      <Point GraphRef="b7fe5" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9fea">
    <BiopaxRef>c65</BiopaxRef>
    <BiopaxRef>b37</BiopaxRef>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b3be1"/>
      <Point GraphRef="f3ec7" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4169513641934981" Shape="None" GraphId="b7ef7"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d7b61">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics>
      <Point GraphRef="e22d1"/>
      <Point GraphRef="bde49" ArrowHead="mim-conversion"/>
      <Anchor Position="0.384292220415481" Shape="None" GraphId="e1bbc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f3899">
    <BiopaxRef>bab</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d6f96"/>
      <Point GraphRef="f3ec7" ArrowHead="mim-conversion"/>
      <Anchor Position="0.23340785080622733" Shape="None" GraphId="b1b7b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b975d">
    <BiopaxRef>bbc</BiopaxRef>
    <BiopaxRef>c65</BiopaxRef>
    <BiopaxRef>b52</BiopaxRef>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics>
      <Point GraphRef="f4615"/>
      <Point GraphRef="b7ef7" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fe7b9">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f3ec7"/>
      <Point GraphRef="bde49" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7795009569337812" Shape="None" GraphId="b7fe5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a6347">
    <Comment>Transport</Comment>
    <BiopaxRef>d2a</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="eb6d4"/>
      <Point GraphRef="b0b60" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e7133">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f3ec7"/>
      <Point GraphRef="e22d1" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7849059471620891" Shape="None" GraphId="a6ac8"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fc82e">
    <Comment>Transport</Comment>
    <BiopaxRef>cbc</BiopaxRef>
    <BiopaxRef>d2a</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="d15da"/>
      <Point GraphRef="eb6d4" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa9e3">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bde49"/>
      <Point/>
      <Point GraphRef="d15da" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7396964481651537" Shape="None" GraphId="beac4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c62a3">
    <BiopaxRef>d5e</BiopaxRef>
    <Graphics>
      <Point GraphRef="c7dfe"/>
      <Point GraphRef="beac4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d1300">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e22d1"/>
      <Point GraphRef="f3ec7" ArrowHead="mim-conversion"/>
      <Anchor Position="0.183384584401236" Shape="None" GraphId="e8bf8"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd4c2">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bde49"/>
      <Point GraphRef="f3ec7" ArrowHead="mim-conversion"/>
      <Anchor Position="0.29306945933453943" Shape="None" GraphId="a5614"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ffa76">
    <BiopaxRef>f2e</BiopaxRef>
    <BiopaxRef>edb</BiopaxRef>
    <BiopaxRef>d5e</BiopaxRef>
    <Graphics>
      <Point GraphRef="f0279"/>
      <Point GraphRef="a5614" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fead0">
    <BiopaxRef>edb</BiopaxRef>
    <Graphics>
      <Point GraphRef="da02f"/>
      <Point GraphRef="e8bf8" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="f8408">
    <BiopaxRef>e73</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="ff0000">
      <Point GraphRef="b64a3"/>
      <Point GraphRef="f8352" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fd708">
    <BiopaxRef>cc5</BiopaxRef>
    <Graphics>
      <Point GraphRef="fe276"/>
      <Point GraphRef="d1610" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ff20c">
    <BiopaxRef>dae</BiopaxRef>
    <Graphics>
      <Point GraphRef="c88e2"/>
      <Point GraphRef="fdb47" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ecc4b">
    <Comment>Type your comment here</Comment>
    <BiopaxRef>c8f</BiopaxRef>
    <Graphics Color="ff9900">
      <Point GraphRef="f70e9"/>
      <Point GraphRef="a1771" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c12f9">
    <BiopaxRef>e60</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="ff9900">
      <Point GraphRef="df1c4"/>
      <Point GraphRef="a1771" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a9093">
    <BiopaxRef>b49</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="ff9900">
      <Point GraphRef="d90d0"/>
      <Point/>
      <Point GraphRef="a1771" ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c7470">
    <BiopaxRef>fc9</BiopaxRef>
    <BiopaxRef>e53</BiopaxRef>
    <Graphics Color="ff0000">
      <Point GraphRef="d36f9"/>
      <Point GraphRef="cfc7b" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bd80f">
    <BiopaxRef>e73</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="ff0000">
      <Point GraphRef="ef1cd"/>
      <Point GraphRef="f1bf9" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ea1fa">
    <Graphics>
      <Point GraphRef="acd2a"/>
      <Point GraphRef="db44f" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e3adc">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f3896"/>
      <Point GraphRef="aa1b2" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cfb59">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f3896"/>
      <Point GraphRef="acd2a" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d0cee">
    <BiopaxRef>fc9</BiopaxRef>
    <BiopaxRef>e53</BiopaxRef>
    <Graphics Color="ff0000">
      <Point GraphRef="e15f7"/>
      <Point GraphRef="c5332" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f501d">
    <Graphics>
      <Point GraphRef="aa1b2"/>
      <Point GraphRef="adca4" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b9249">
    <BiopaxRef>fc9</BiopaxRef>
    <BiopaxRef>e53</BiopaxRef>
    <Graphics Color="ff0000">
      <Point GraphRef="ef1cd"/>
      <Point GraphRef="c761d" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a82ae">
    <BiopaxRef>fc9</BiopaxRef>
    <BiopaxRef>e53</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="ff0000">
      <Point GraphRef="eb6d4"/>
      <Point GraphRef="a1771" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e8771">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="db44f"/>
      <Point GraphRef="a1771" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e19b6">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="db44f"/>
      <Point GraphRef="c761d" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c2b73">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="db44f"/>
      <Point GraphRef="cfc7b" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b9406">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="db44f"/>
      <Point GraphRef="c5332" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e1bde">
    <BiopaxRef>d88</BiopaxRef>
    <Graphics Color="ff0000">
      <Point GraphRef="fe276"/>
      <Point GraphRef="cb3ed" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cff5c">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="adca4"/>
      <Point GraphRef="cb3ed" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e937d">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="adca4"/>
      <Point GraphRef="f8352" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="de7ca">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="adca4"/>
      <Point GraphRef="f1bf9" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="da597">
    <Graphics LineStyle="Broken">
      <Point/>
      <Point GraphRef="b969a" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d0c68">
    <Graphics>
      <Point/>
      <Point GraphRef="c2f59" ArrowHead="mim-binding"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e014c">
    <Graphics>
      <Point/>
      <Point GraphRef="f2a8d" ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a2374">
    <Graphics>
      <Point/>
      <Point GraphRef="c2c61" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f5793">
    <Graphics>
      <Point/>
      <Point GraphRef="ae61b" ArrowHead="mim-inhibition"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f24b6">
    <Graphics>
      <Point/>
      <Point GraphRef="d2a52" ArrowHead="mim-catalysis"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a97ca">
    <Graphics Color="ff0000">
      <Point/>
      <Point GraphRef="a2ada" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e5920">
    <Graphics Color="ff9900">
      <Point/>
      <Point GraphRef="e922a" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Type II B" GraphId="aa1b2">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Cellular &#10;transcription&#10;factor" GraphId="d1610">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Mutation leading&#10;to different&#10;phenotype" GraphId="e922a">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Lipid signaling" GraphId="fdb47">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Type II A" GraphId="acd2a">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Liver" GraphId="d5742">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Transport&#10;" GraphId="b969a">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Binding" GraphId="c2f59">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Inhibition" GraphId="ae61b">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Conversion" GraphId="f2a8d">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Gene/protein" GraphId="f67dc">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Metabolite" GraphId="ee247">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Catalysis" GraphId="d2a52">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Stimulation" GraphId="c2c61">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Mutations" GraphId="a2ada">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Legend" GraphId="e8127">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Shape GraphId="ece2a">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape TextLabel="x" GraphId="da2f0">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="aefcb">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="x" GraphId="bf6a1">
    <Graphics ShapeType="Rectangle" Color="0000ff"/>
  </Shape>
  <Group GroupId="eb1af" GraphId="b0b60" Style="Group"/>
  <Group GroupId="b6ea1" GraphId="b3fe7" Style="Complex"/>
  <Group GroupId="e98ed" GraphId="d8f25" Style="Group"/>
  <Group GroupId="bc8e0" GraphId="f4615" Style="Complex"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d2a">
      <bp:ID >22461740</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis.</bp:TITLE>
      <bp:SOURCE >Yale J Biol Med</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Go GW</bp:AUTHORS>
      <bp:AUTHORS >Mani A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e73">
      <bp:ID >30307446</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.</bp:TITLE>
      <bp:SOURCE >Rev Invest Clin</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Bello-Chavolla OY</bp:AUTHORS>
      <bp:AUTHORS >Kuri-Garc&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#173;a A</bp:AUTHORS>
      <bp:AUTHORS >R&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#173;os-R&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#173;os M</bp:AUTHORS>
      <bp:AUTHORS >Vargas-V&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#161;zquez A</bp:AUTHORS>
      <bp:AUTHORS >Cort&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169;s-Arroyo JE</bp:AUTHORS>
      <bp:AUTHORS >Tapia-Gonz&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#161;lez G</bp:AUTHORS>
      <bp:AUTHORS >Cruz-Bautista I</bp:AUTHORS>
      <bp:AUTHORS >Aguilar-Salinas CA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f0a">
      <bp:ID >26725424</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis.</bp:TITLE>
      <bp:SOURCE >Biol Pharm Bull</bp:SOURCE>
      <bp:YEAR >2016</bp:YEAR>
      <bp:AUTHORS >Morita SY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >familial hyperlipidemia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:1168</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000013</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c8f">
      <bp:ID >14673705</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred.</bp:TITLE>
      <bp:SOURCE >J Hum Genet</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Sato K</bp:AUTHORS>
      <bp:AUTHORS >Emi M</bp:AUTHORS>
      <bp:AUTHORS >Ezura Y</bp:AUTHORS>
      <bp:AUTHORS >Fujita Y</bp:AUTHORS>
      <bp:AUTHORS >Takada D</bp:AUTHORS>
      <bp:AUTHORS >Ishigami T</bp:AUTHORS>
      <bp:AUTHORS >Umemura S</bp:AUTHORS>
      <bp:AUTHORS >Xin Y</bp:AUTHORS>
      <bp:AUTHORS >Wu LL</bp:AUTHORS>
      <bp:AUTHORS >Larrinaga-Shum S</bp:AUTHORS>
      <bp:AUTHORS >Stephenson SH</bp:AUTHORS>
      <bp:AUTHORS >Hunt SC</bp:AUTHORS>
      <bp:AUTHORS >Hopkins PN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2e">
      <bp:ID >26247089</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Introduction to Lipids and Lipoproteins</bp:TITLE>
      <bp:SOURCE />
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Feingold KR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc5">
      <bp:ID >18768914</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >USF1/2 transcription factor DNA-binding activity is induced during rat Sertoli cell differentiation.</bp:TITLE>
      <bp:SOURCE >Biol Reprod</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Wood MA</bp:AUTHORS>
      <bp:AUTHORS >Walker WH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d5e">
      <bp:ID >24426196</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Association of CETP and LIPC Gene Polymorphisms with HDL and LDL Sub-fraction Levels in a Group of Indian Subjects: A Cross-Sectional Study.</bp:TITLE>
      <bp:SOURCE >Indian J Clin Biochem</bp:SOURCE>
      <bp:YEAR >2013</bp:YEAR>
      <bp:AUTHORS >Todur SP</bp:AUTHORS>
      <bp:AUTHORS >Ashavaid TF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b49">
      <bp:ID >12910492</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: intra-familial association study in an eight-generation hyperlipidemic kindred.</bp:TITLE>
      <bp:SOURCE >Am J Med Genet A</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Takada D</bp:AUTHORS>
      <bp:AUTHORS >Ezura Y</bp:AUTHORS>
      <bp:AUTHORS >Ono S</bp:AUTHORS>
      <bp:AUTHORS >Iino Y</bp:AUTHORS>
      <bp:AUTHORS >Katayama Y</bp:AUTHORS>
      <bp:AUTHORS >Xin Y</bp:AUTHORS>
      <bp:AUTHORS >Wu LL</bp:AUTHORS>
      <bp:AUTHORS >Larringa-Shum S</bp:AUTHORS>
      <bp:AUTHORS >Stephenson SH</bp:AUTHORS>
      <bp:AUTHORS >Hunt SC</bp:AUTHORS>
      <bp:AUTHORS >Hopkins PN</bp:AUTHORS>
      <bp:AUTHORS >Emi M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c63">
      <bp:ID >25470695</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Targeting APOC3 in the familial chylomicronemia syndrome.</bp:TITLE>
      <bp:SOURCE >N Engl J Med</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Gaudet D</bp:AUTHORS>
      <bp:AUTHORS >Brisson D</bp:AUTHORS>
      <bp:AUTHORS >Tremblay K</bp:AUTHORS>
      <bp:AUTHORS >Alexander VJ</bp:AUTHORS>
      <bp:AUTHORS >Singleton W</bp:AUTHORS>
      <bp:AUTHORS >Hughes SG</bp:AUTHORS>
      <bp:AUTHORS >Geary RS</bp:AUTHORS>
      <bp:AUTHORS >Baker BF</bp:AUTHORS>
      <bp:AUTHORS >Graham MJ</bp:AUTHORS>
      <bp:AUTHORS >Crooke RM</bp:AUTHORS>
      <bp:AUTHORS >Witztum JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e51">
      <bp:ID >20301485</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Familial Lipoprotein Lipase Deficiency</bp:TITLE>
      <bp:SOURCE />
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Burnett JR</bp:AUTHORS>
      <bp:AUTHORS >Hooper AJ</bp:AUTHORS>
      <bp:AUTHORS >Hegele RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd8">
      <bp:ID >14592533</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders.</bp:TITLE>
      <bp:SOURCE >Int J Biochem Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Rhainds D</bp:AUTHORS>
      <bp:AUTHORS >Brissette L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4b">
      <bp:ID >28882953</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >&lt;i&gt;SCARB1&lt;/i&gt;Gene Polymorphisms and HDL Subfractions in Coronary Artery Disease.</bp:TITLE>
      <bp:SOURCE >In Vivo</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Ayhan H</bp:AUTHORS>
      <bp:AUTHORS >Gormus U</bp:AUTHORS>
      <bp:AUTHORS >Isbir S</bp:AUTHORS>
      <bp:AUTHORS >Yilmaz SG</bp:AUTHORS>
      <bp:AUTHORS >Isbir T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >familial combined hyperlipidemia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:13809</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e60">
      <bp:ID >12522687</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.</bp:TITLE>
      <bp:SOURCE >J Hum Genet</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Takada D</bp:AUTHORS>
      <bp:AUTHORS >Emi M</bp:AUTHORS>
      <bp:AUTHORS >Ezura Y</bp:AUTHORS>
      <bp:AUTHORS >Nobe Y</bp:AUTHORS>
      <bp:AUTHORS >Kawamura K</bp:AUTHORS>
      <bp:AUTHORS >Iino Y</bp:AUTHORS>
      <bp:AUTHORS >Katayama Y</bp:AUTHORS>
      <bp:AUTHORS >Xin Y</bp:AUTHORS>
      <bp:AUTHORS >Wu LL</bp:AUTHORS>
      <bp:AUTHORS >Larringa-Shum S</bp:AUTHORS>
      <bp:AUTHORS >Stephenson SH</bp:AUTHORS>
      <bp:AUTHORS >Hunt SC</bp:AUTHORS>
      <bp:AUTHORS >Hopkins PN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b52">
      <bp:ID >31462513</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2019</bp:YEAR>
      <bp:AUTHORS >Obinata H</bp:AUTHORS>
      <bp:AUTHORS >Kuo A</bp:AUTHORS>
      <bp:AUTHORS >Wada Y</bp:AUTHORS>
      <bp:AUTHORS >Swendeman S</bp:AUTHORS>
      <bp:AUTHORS >Liu CH</bp:AUTHORS>
      <bp:AUTHORS >Blaho VA</bp:AUTHORS>
      <bp:AUTHORS >Nagumo R</bp:AUTHORS>
      <bp:AUTHORS >Satoh K</bp:AUTHORS>
      <bp:AUTHORS >Izumi T</bp:AUTHORS>
      <bp:AUTHORS >Hla T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bbc">
      <bp:ID >32120838</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Association between the&lt;i&gt;APOA2&lt;/i&gt;rs3813627 Single Nucleotide Polymorphism and HDL and APOA1 Levels Through BMI.</bp:TITLE>
      <bp:SOURCE >Biomedicines</bp:SOURCE>
      <bp:YEAR >2020</bp:YEAR>
      <bp:AUTHORS >Boughanem H</bp:AUTHORS>
      <bp:AUTHORS >Bandera-Merch&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#161;n B</bp:AUTHORS>
      <bp:AUTHORS >Hern&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#161;ndez-Alonso P</bp:AUTHORS>
      <bp:AUTHORS >Moreno-Morales N</bp:AUTHORS>
      <bp:AUTHORS >Tinahones FJ</bp:AUTHORS>
      <bp:AUTHORS >Lozano J</bp:AUTHORS>
      <bp:AUTHORS >Morcillo S</bp:AUTHORS>
      <bp:AUTHORS >Macias-Gonzalez M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d88">
      <bp:ID >9537421</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.</bp:TITLE>
      <bp:SOURCE >Nat Genet</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Pajukanta P</bp:AUTHORS>
      <bp:AUTHORS >Nuotio I</bp:AUTHORS>
      <bp:AUTHORS >Terwilliger JD</bp:AUTHORS>
      <bp:AUTHORS >Porkka KV</bp:AUTHORS>
      <bp:AUTHORS >Ylitalo K</bp:AUTHORS>
      <bp:AUTHORS >Pihlajam&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#164;ki J</bp:AUTHORS>
      <bp:AUTHORS >Suomalainen AJ</bp:AUTHORS>
      <bp:AUTHORS >Syv&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#164;nen AC</bp:AUTHORS>
      <bp:AUTHORS >Lehtim&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#226;&#8364;&#160;&#195;&#162;&#226;&#8218;&#172;&#226;&#8222;&#162;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#194;&#160;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#162;&#226;&#8364;&#382;&#194;&#162;&#195;&#402;&#198;&#8217;&#195;&#8224;&#226;&#8364;&#8482;&#195;&#402;&#194;&#162;&#195;&#162;&#226;&#8364;&#353;&#194;&#172;&#195;&#8230;&#194;&#161;&#195;&#402;&#198;&#8217;&#195;&#162;&#226;&#8218;&#172;&#197;&#161;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#164;ki T</bp:AUTHORS>
      <bp:AUTHORS >Viikari JS</bp:AUTHORS>
      <bp:AUTHORS >Laakso M</bp:AUTHORS>
      <bp:AUTHORS >Taskinen MR</bp:AUTHORS>
      <bp:AUTHORS >Ehnholm C</bp:AUTHORS>
      <bp:AUTHORS >Peltonen L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbc">
      <bp:ID >31676439</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta Mol Cell Biol Lipids</bp:SOURCE>
      <bp:YEAR >2020</bp:YEAR>
      <bp:AUTHORS >Lucero D</bp:AUTHORS>
      <bp:AUTHORS >Islam P</bp:AUTHORS>
      <bp:AUTHORS >Freeman LA</bp:AUTHORS>
      <bp:AUTHORS >Jin X</bp:AUTHORS>
      <bp:AUTHORS >Pryor M</bp:AUTHORS>
      <bp:AUTHORS >Tang J</bp:AUTHORS>
      <bp:AUTHORS >Kruth HS</bp:AUTHORS>
      <bp:AUTHORS >Remaley AT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="edb">
      <bp:ID >23055695</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib.</bp:TITLE>
      <bp:SOURCE >Drug Des Devel Ther</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Goldberg AS</bp:AUTHORS>
      <bp:AUTHORS >Hegele RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e47">
      <bp:ID >30420806</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen.</bp:TITLE>
      <bp:SOURCE >Front Pharmacol</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Huang A</bp:AUTHORS>
      <bp:AUTHORS >Sun D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e53">
      <bp:ID >27809445</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b55">
      <bp:ID >25110901</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells.</bp:TITLE>
      <bp:SOURCE >Curr Opin Lipidol</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Lagace TA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b37">
      <bp:ID >30333156</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Geller AS</bp:AUTHORS>
      <bp:AUTHORS >Polisecki EY</bp:AUTHORS>
      <bp:AUTHORS >Diffenderfer MR</bp:AUTHORS>
      <bp:AUTHORS >Asztalos BF</bp:AUTHORS>
      <bp:AUTHORS >Karathanasis SK</bp:AUTHORS>
      <bp:AUTHORS >Hegele RA</bp:AUTHORS>
      <bp:AUTHORS >Schaefer EJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc9">
      <bp:ID >24404629</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Familial Hypercholesterolemia</bp:TITLE>
      <bp:SOURCE />
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Youngblom E</bp:AUTHORS>
      <bp:AUTHORS >Pariani M</bp:AUTHORS>
      <bp:AUTHORS >Knowles JW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bab">
      <bp:ID >28766509</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol.</bp:TITLE>
      <bp:SOURCE >Anatol J Cardiol</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Tosheska Trajkovska K</bp:AUTHORS>
      <bp:AUTHORS >Topuzovska S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dae">
      <bp:ID >29298899</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Edin ML</bp:AUTHORS>
      <bp:AUTHORS >Hamedani BG</bp:AUTHORS>
      <bp:AUTHORS >Gruzdev A</bp:AUTHORS>
      <bp:AUTHORS >Graves JP</bp:AUTHORS>
      <bp:AUTHORS >Lih FB</bp:AUTHORS>
      <bp:AUTHORS >Arbes SJ 3rd</bp:AUTHORS>
      <bp:AUTHORS >Singh R</bp:AUTHORS>
      <bp:AUTHORS >Orjuela Leon AC</bp:AUTHORS>
      <bp:AUTHORS >Bradbury JA</bp:AUTHORS>
      <bp:AUTHORS >DeGraff LM</bp:AUTHORS>
      <bp:AUTHORS >Hoopes SL</bp:AUTHORS>
      <bp:AUTHORS >Arand M</bp:AUTHORS>
      <bp:AUTHORS >Zeldin DC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fdd">
      <bp:ID >29100061</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.</bp:TITLE>
      <bp:SOURCE >Atherosclerosis</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Wolska A</bp:AUTHORS>
      <bp:AUTHORS >Dunbar RL</bp:AUTHORS>
      <bp:AUTHORS >Freeman LA</bp:AUTHORS>
      <bp:AUTHORS >Ueda M</bp:AUTHORS>
      <bp:AUTHORS >Amar MJ</bp:AUTHORS>
      <bp:AUTHORS >Sviridov DO</bp:AUTHORS>
      <bp:AUTHORS >Remaley AT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c65">
      <bp:ID >30249788</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >N-terminal mutation of apoA-I and interaction with ABCA1 reveal mechanisms of nascent HDL biogenesis.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2019</bp:YEAR>
      <bp:AUTHORS >Liu M</bp:AUTHORS>
      <bp:AUTHORS >Mei X</bp:AUTHORS>
      <bp:AUTHORS >Herscovitz H</bp:AUTHORS>
      <bp:AUTHORS >Atkinson D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >familial hypercholesterolemia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:13810</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
  </Biopax>
</Pathway>